Bio-Logic Systems Corp. (BLSC) |
|
CEOCFO Current
Issue |
This is a printer friendly page! A strong balance sheet, sales growth in
disposable products and new technology releases brightening the future for Bio-Logic
Systems Bio-Logic Systems Corp. Roderick G. Johnson and Gabriel
Raviv, Chairman & CEO Interview Conducted by: CEOCFOinterviews.com BIOs: Gabriel Raviv has been a Director of the Company since it commenced operations in March 1979. He became President and Chief Executive Officer of the Company in February 1981. In September 1999, Dr. Raviv relinquished the role of President retaining the position of Chief Executive Officer of the Company. Dr. Raviv formerly served as director of the Clinical Research Instrumentation Laboratory at Evanston Hospital (an affiliate of Northwestern University) and is currently Adjunct Professor at Northwestern University. Dr. Raviv received his M.S. and Ph.D. degrees in Electrical Engineering and Computer Sciences from Northwestern University. Roderick Johnson
joined the Company in September 1999 as President, Chief Operating Officer and a member of
the Board of Directors. He founded the Neurocare Group in 1994 and served as Chairman,
President and Chief Executive officer until 1999. From 1992 through 1994, Mr. Johnson
served as Chief Executive Officer in Residence at Weiss, Peck & Greer and the
Continental Illinois Venture Capital Corporation. In addition, from 1988 through 1991, Mr.
Johnson was President and Chief Executive Officer of Domino Amjet, Inc. Each area has its own market potential: - - Hearing assessment: Automated hearing screening in newborns, aimed at early detection of hearing loss, is one of the fastest growing markets. Of the 4 million births in the U.S. each year, approximately 3 of every 1,000 infants are born hearing impaired. This focus on early intervention has generated a growing need for improved diagnostic equipment that can quickly and accurately identify and assess the babys hearing loss. - - Sleep disorders: There are a wide range of sleep disorders including sleep apnea, narcolepsy, insomnia, pediatric disorders and many others. These disorders affect the quality of life, pose a threat to public safety on the road and at work, and can be fatal. Its been estimated that the diagnostic market will grow to $100 million annually within five years. - - Electrical activity in the brain (EEG): Long-term monitoring is used to diagnose disease, monitor the efficacy of medications and obtain information critical for surgical treatment with indicated. The market is in transition from analog to digital video technology. Digital video systems save both EEG and video records in digital form, replacing paper and videotapes. Product Offerings: - - ABaer - - CUB (ABR) - - AuDX® (OAE) - - Navigator® Pro - - Scout® Sport - - Ceegraph - - Ceegraph Traveler® - - Universal Reader - - Sleepscan - - Airflow Pressure Transducer
|
To view Releases highlight & left click on the company name!
|
ceocfointerviews.com does not purchase or
make
recommendation on stocks based on the interviews published.
.